本頁面由Tiger Trade Technology Pte. Ltd.提供服務

科興生物

6.47
0.0000
成交量:- -
成交額:- -
市值:3.89億
市盈率:6.66
高:6.47
開:6.47
低:6.47
收:6.47
52周最高:6.47
52周最低:6.47
股本:6,006.07萬
流通股本:3,116.90萬
量比:0.52
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):0.9710
每股收益(LYR):1.06
淨資產收益率:25.15%
總資產收益率:11.46%
市淨率:0.52
市盈率(LYR):6.13

資料載入中...

2024/09/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/20

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/05

SEC問詢函

Form CORRESP - Correspondence
2023/09/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/02

SEC問詢函

Form CORRESP - Correspondence
2023/07/11

SEC問詢函

Form CORRESP - Correspondence
2023/05/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/12/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]